戻る Agenda
Session 1: The Basics: Why We Do What We Do
Session Chair(s)
JP Clement, MD
Founder and Principal
JPCC Associates, United States
This session provides longitudinal context for the evolving safety profile of a medicinal product and why continuous safety monitoring and evaluation are important. Three case studies underscore the importance of impeccable attention to drug safety during all phases of clinical development.